Pertussis causes substantial morbidity among adolescents and adults, as well as other
persons in contact with affected individuals. In the context of widespread childhood …

This multicentre study was designed to establish the reactogenicity and immunogenicity
profiles of primary and booster vaccination with diphtheria, tetanus, and pertussis whole-cell …

In a clinical trial, adolescents who had received a booster dose of reduced dose diphtheria–
tetanus-5-component acellular pertussis vaccine (Adacel®, Tdap) 5 years earlier maintained …

The recent increase of pertussis in young adults in Japan is hypothesized to be due in part
to waning protection from the acellular pertussis vaccine. While a booster immunization may …

An open randomised controlled multicentre study compared the immunogenicity and
reactogenicity of three vaccines given by injection at two, three and four months of age …

This Policy Statement was retired January 2015. The American Academy of Pediatrics and
the Centers for Disease Control and Prevention are amending previous recommendations …

Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

Background. A household contact substudy was performed as part of a prospective, cohort
pertussis vaccine efficacy trial in Germany. Design. Infants received four doses of either the …

Ideally, combination vaccines should not only be safe and effective, but also integrate
smoothly into the vaccination schedule and provide advantages over the use of separately …

Background This study evaluated immunogenicity and safety of the adjuvanted recombinant
zoster vaccine (RZV) and the reduced-antigen-content diphtheria-tetanus-acellular pertussis …